FDA
-
-
-
-
-
-
-
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NurExone's Strategic Update: Submission of OTCQB Listing ApplicationĀ to Initiate US financial presence
-
-
-
-
-
-
-
NurExone Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
335,848 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


